Patents by Inventor Fernando Huerta

Fernando Huerta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OXAZOLO[4,5-c]PYRIDINE SUBSTITUTED PYRAZINE
    Publication number: 20110118275
    Abstract: The present invention relates to a compound of formula (I) wherein R1 is hydrogen or methyl, or a pharmaceutically acceptable salt thereof, pharmaceutical formulations containing said compound, to the use of said active compound in therapy, as well as intermediates.
    Type: Application
    Filed: November 12, 2010
    Publication date: May 19, 2011
    Applicant: ASTRAZENECA AB
    Inventors: Kristofer Ahlin, Per I. ARVIDSSON, Ulrika YNGVE, Fernando HUERTA
  • Pyrimidine Derivatives and Their Use for Treating Bone-Related Disorders
    Publication number: 20110028489
    Abstract: The present invention relates to a new use of pyrimidine derivatives of formula I, as a free base or a pharmaceutically acceptable salt thereof in the manufacture of a medicament in the treatment and/or prophylaxis of Alzheimer's Disease:
    Type: Application
    Filed: August 16, 2010
    Publication date: February 3, 2011
    Inventors: Lars Andersson, Stefan Berg, Jeremy Burrows, Sven Hellberg, Fernando Huerta, Tobias Rein
  • Pyrimidine Derivatives and Their Use in Therapy as well as the Use of Pyrimidine Derivatives in the Manufacture of a Medicament for Prevention and/or Treatment of Alzheimer's Disease
    Publication number: 20090105252
    Abstract: Compounds of formula I wherein R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as defined in the specification as a base or a pharmaceutically acceptable salt, solvate or solvate of salt thereof, processes for their preparation, new intermediates used therein, pharmaceutical formulations containing said compounds and to the use of said compounds in therapy.
    Type: Application
    Filed: October 2, 2006
    Publication date: April 23, 2009
    Applicant: AstraZeneca AB
    Inventors: Lars Andersson, Erwan Arzel, Stefan Berg, Jeremy Burrows, Sven Hellberg, Fernando Huerta, Torben Pedersen, Tobias Rein, Didier Rotticci, Karin Staaf, Dominika Turek
  • Use of Pyrimidine Derivatives in the Manufacture of a Medicament for Prevention and/or Treatment of Alzheimer's Disease
    Publication number: 20080214560
    Abstract: Pyrimidine derivatives of formula I, wherein R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as defined in the specification, as a base or a pharmaceutically acceptable salt thereof in the manufacture of pharmaceutical compositions and in the treatment or prophylaxis of Alzheimer's Disease.
    Type: Application
    Filed: October 2, 2006
    Publication date: September 4, 2008
    Applicant: AstraZeneca AB
    Inventors: Lars Andersson, Stefan Berg, Jeremy Burrows, Sven Hellberg, Fernando Huerta, Tobias Rein
  • New Compounds II
    Publication number: 20080188503
    Abstract: The present invention relates to a compound of formula (I): as a free base or a pharmaceutically acceptable salt thereof. The present invention also relates to pharmaceutical formulations containing said compound and to the use of said compound in therapy. The present invention further relates to a process for the preparation of the compound of formula (I).
    Type: Application
    Filed: June 27, 2007
    Publication date: August 7, 2008
    Applicant: AstraZenaca AB
    Inventors: Jeremy Burrows, Fernando Huerta, Tobias Rein, Didier Rotticci, Karin Staaf, Dominika Turek
  • New Compounds I
    Publication number: 20080188502
    Abstract: The present invention relates to a compound of formula (I): as a free base or a pharmaceutically acceptable salt thereof. The present invention also relates to pharmaceutical formulations containing said compound and to the use of said compound in therapy. The present invention further relates to a process for the preparation of compound of formula (I) and to new intermediates used therein.
    Type: Application
    Filed: June 27, 2007
    Publication date: August 7, 2008
    Applicant: AstraZeneca AB
    Inventors: Jeremy Burrows, Fernando Huerta, Fredrik Lake, Torben Pedersen, Didier Rotticci, Tobias Rein, Karin Staaf, Ulrika Yngve